Free Trial

HealthEquity (HQY) Stock Price, News & Analysis

$79.27
-0.57 (-0.71%)
(As of 05/24/2024 ET)
Today's Range
$79.08
$80.27
50-Day Range
$75.85
$83.53
52-Week Range
$54.09
$84.49
Volume
317,975 shs
Average Volume
522,361 shs
Market Capitalization
$6.90 billion
P/E Ratio
123.86
Dividend Yield
N/A
Price Target
$96.17

HealthEquity MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
21.3% Upside
$96.17 Price Target
Short Interest
Healthy
3.37% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.16mentions of HealthEquity in the last 14 days
Based on 15 Articles This Week
Insider Trading
Selling Shares
$5.48 M Sold Last Quarter
Proj. Earnings Growth
31.60%
From $2.12 to $2.79 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.96 out of 5 stars

Medical Sector

238th out of 923 stocks

Business Services, Not Elsewhere Classified Industry

36th out of 91 stocks

HQY stock logo

About HealthEquity Stock (NASDAQ:HQY)

HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is based in Draper, Utah.

HQY Stock Price History

HQY Stock News Headlines

HealthEquity, Inc. (HQY)
HQY Quantitative Stock Analysis
Jefferies Keeps Their Buy Rating on Healthequity (HQY)
Barclays Keeps Their Buy Rating on Healthequity (HQY)
Recap: HealthEquity Q4 Earnings
See More Headlines
Receive HQY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HealthEquity and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/19/2024
Today
5/25/2024
Next Earnings (Confirmed)
6/03/2024
Fiscal Year End
1/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Business services, not elsewhere classified
Sub-Industry
N/A
Current Symbol
NASDAQ:HQY
Employees
3,150
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$96.17
High Stock Price Target
$110.00
Low Stock Price Target
$72.00
Potential Upside/Downside
+21.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
11 Analysts

Profitability

Net Income
$55.71 million
Pretax Margin
7.51%

Debt

Sales & Book Value

Annual Sales
$999.59 million
Cash Flow
$3.39 per share
Book Value
$23.72 per share

Miscellaneous

Free Float
84,661,000
Market Cap
$6.90 billion
Optionable
Optionable
Beta
0.55
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

HQY Stock Analysis - Frequently Asked Questions

Should I buy or sell HealthEquity stock right now?

11 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for HealthEquity in the last twelve months. There are currently 11 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" HQY shares.
View HQY analyst ratings
or view top-rated stocks.

What is HealthEquity's stock price target for 2024?

11 Wall Street analysts have issued 1-year price targets for HealthEquity's stock. Their HQY share price targets range from $72.00 to $110.00. On average, they anticipate the company's stock price to reach $96.17 in the next twelve months. This suggests a possible upside of 21.3% from the stock's current price.
View analysts price targets for HQY
or view top-rated stocks among Wall Street analysts.

How have HQY shares performed in 2024?

HealthEquity's stock was trading at $66.30 at the start of the year. Since then, HQY shares have increased by 19.6% and is now trading at $79.27.
View the best growth stocks for 2024 here
.

When is HealthEquity's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, June 3rd 2024.
View our HQY earnings forecast
.

How can I listen to HealthEquity's earnings call?

HealthEquity will be holding an earnings conference call on Monday, June 3rd at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

How were HealthEquity's earnings last quarter?

HealthEquity, Inc. (NASDAQ:HQY) posted its quarterly earnings results on Tuesday, March, 19th. The company reported $0.50 earnings per share for the quarter, topping analysts' consensus estimates of $0.42 by $0.08. The company earned $262.39 million during the quarter, compared to the consensus estimate of $258.56 million. HealthEquity had a trailing twelve-month return on equity of 6.91% and a net margin of 5.57%.

What guidance has HealthEquity issued on next quarter's earnings?

HealthEquity updated its FY 2025 earnings guidance on Thursday, April, 11th. The company provided EPS guidance of 2.790-2.960 for the period, compared to the consensus estimate of 2.830. The company issued revenue guidance of $1.1 billion-$1.2 billion, compared to the consensus revenue estimate of $1.2 billion.

What is Jon Kessler's approval rating as HealthEquity's CEO?

359 employees have rated HealthEquity Chief Executive Officer Jon Kessler on Glassdoor.com. Jon Kessler has an approval rating of 95% among the company's employees. This puts Jon Kessler in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. 69.0% of employees surveyed would recommend working at HealthEquity to a friend.

What other stocks do shareholders of HealthEquity own?

Based on aggregate information from My MarketBeat watchlists, some companies that other HealthEquity investors own include NVIDIA (NVDA), Shopify (SHOP), Block (SQ), Okta (OKTA), PayPal (PYPL), Twilio (TWLO), Trade Desk (TTD), Alibaba Group (BABA), Casino, Guichard-Perrachon Societe Anonyme (COP) and Input Capital (INP).

Who are HealthEquity's major shareholders?

HealthEquity's stock is owned by many different retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (10.22%), Wasatch Advisors LP (8.64%), Motley Fool Asset Management LLC (4.38%), Clearbridge Investments LLC (2.72%), Allspring Global Investments Holdings LLC (1.30%) and Allspring Global Investments Holdings LLC (1.30%). Insiders that own company stock include Adrian T Dillon, Angelique Christine Hill, Darcy G Mott, Darcy G Mott, Debra Charlotte Mccowan, Delano Ladd, Edward Bloomberg, Elimelech Rosner, Evelyn S Dilsaver, Frank Corvino, Gayle Furgurson Wellborn, Ian Sacks, Jon Kessler, Larry L Trittschuh, Stuart B Parker, Tyson D Murdock and William Robert Otten.
View institutional ownership trends
.

How do I buy shares of HealthEquity?

Shares of HQY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:HQY) was last updated on 5/26/2024 by MarketBeat.com Staff

From Our Partners